ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Here’s What’s Driving Crispr Therapeutics AG Higher Today … – Madison.com

Continue reading

2018-01-23 Michael Zand NEWS

Here’s What’s Driving Crispr Therapeutics AG Higher Today – Motley Fool


Madison.com

Here’s What’s Driving Crispr Therapeutics AG Higher Today …
Madison.com
Shares of Crispr Therapeutics AG (NASDAQ: CRSP), a start-up biotech using eponymous gene-editing technology to develop new therapies, popped 15.2% in early-morning trading on Tuesday. Shares have settled to a gain of 14.4% as of 12:10 p.m. EST after …
Ipswich Investment Management Co. Inc. Takes $1.13 Million Position in Crispr Therapeutics AG (NASDAQ:CRSP)The Ledger Gazette
Shares that proliferate your speculations: CRISPR Therapeutics AG (CRSP)The News Journal
Analyst Upgrades – Crispr Therapeutics (NASDAQ:CRSP) Stock Gets Upgraded By SunTrust Banks from Hold to BuyMarket Exclusive
Post Analyst –Norman Weekly –Aiken Advocate
all 25 news articles »
Continue reading

2018-01-23 Michael Zand NEWS

Here’s What’s Driving Crispr Therapeutics AG Higher Today – Motley Fool


Norman Weekly

Here’s What’s Driving Crispr Therapeutics AG Higher Today
Motley Fool
In the U.S., Crispr Therapeutics and its peers are still awaiting regulatory reviews that would allow them to begin human testing with their first new therapy candidates. Perhaps fearing international condemnation for playing fast and loose with …
Crispr Therapeutics (CRSP) Lifted to Buy at SunTrust BanksThe Ledger Gazette
Analyst Upgrades – Crispr Therapeutics (NASDAQ:CRSP) Stock Gets Upgraded By SunTrust Banks from Hold to BuyMarket Exclusive
Stocks that can influence your investment – CRISPR Therapeutics AG (NASDAQ:CRSP)The News Journal
Post Analyst –Norman Weekly –TrueBlueTribune
all 24 news articles »
Continue reading

2018-01-23 Michael Zand NEWS

Here’s What’s Driving Crispr Therapeutics AG Higher Today – Motley Fool


Norman Weekly

Here’s What’s Driving Crispr Therapeutics AG Higher Today
Motley Fool
In the U.S., Crispr Therapeutics and its peers are still awaiting regulatory reviews that would allow them to begin human testing with their first new therapy candidates. Perhaps fearing international condemnation for playing fast and loose with …
Crispr Therapeutics (CRSP) Lifted to Buy at SunTrust BanksThe Ledger Gazette
Analyst Upgrades – Crispr Therapeutics (NASDAQ:CRSP) Stock Gets Upgraded By SunTrust Banks from Hold to BuyMarket Exclusive
Stocks that can influence your investment – CRISPR Therapeutics AG (NASDAQ:CRSP)The News Journal
Post Analyst –Norman Weekly –Aiken Advocate
all 24 news articles »
Continue reading

2018-01-23 Michael Zand NEWS

The continuing CRISPR patent battle: the Broad Institute loses a key European patent – MedCity News

MedCity NewsThe continuing CRISPR patent battle: the Broad Institute loses a key European patentMedCity NewsIn the ongoing worldwide patent battle over the CRISPR Cas9 gene-editing technology between the Broad Institute/MIT (Zhang, et al.), and the Uni… Continue reading

2018-01-23 Michael Zand NEWS

CAR T-Cell Therapy an Emerging Explosion in Myeloma Paradigm – OncLive

CAR T-Cell Therapy an Emerging Explosion in Myeloma ParadigmOncLiveThere are T-cell receptor (TCR) therapies, such as NY-ESO-1, and there are several clinical trials for this, one of which we are going to be participating in at UCSF. In addition, we ta… Continue reading

2018-01-23 Michael Zand NEWS

Nobel laureate suggests he could fall on sword over colleague’s bogus paper – Science Magazine


Norman Weekly

Here’s What’s Driving Crispr Therapeutics AG Higher Today
Motley Fool
In the U.S., Crispr Therapeutics and its peers are still awaiting regulatory reviews that would allow them to begin human testing with their first new therapy candidates. Perhaps fearing international condemnation for playing fast and loose with …
Crispr Therapeutics (CRSP) Lifted to Buy at SunTrust BanksThe Ledger Gazette
Analyst Upgrades – Crispr Therapeutics (NASDAQ:CRSP) Stock Gets Upgraded By SunTrust Banks from Hold to BuyMarket Exclusive
Stocks that can influence your investment – CRISPR Therapeutics AG (NASDAQ:CRSP)The News Journal
Post Analyst –Norman Weekly –Aiken Advocate
all 24 news articles »
Continue reading

2018-01-23 Michael Zand NEWS

The Past and Future of Gene Therapy – Specialty Pharmacy Times

The Past and Future of Gene TherapySpecialty Pharmacy TimesThe FDA approved the first gene therapy in 2017, marking a significant moment in the history of health care. Since tisagenlecleucel (Kymriah) was approved for refractory B-cell precursor acute … Continue reading

2018-01-23 Michael Zand NEWS
  • 1
  • …
  • 627
  • 628
  • 629
  • 630
  • 631
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Science Magazine

Nobel laureate suggests he could fall on sword over colleague’s bogus paper
Science Magazine
The paper in question appeared in the journal Stem Cell Reports in March 2017. According to a report signed by Yamanaka posted on CiRA’s website, after receiving allegations of possibly fraudulent images, CiRA and Kyoto University started a preliminary …

and more »